| 2011 | | 2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea | 김혜진 |
| 2020 | | Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea | 김대중 |
| 2011 | | Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naive Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study | 이관우 |
| 2013 | | Diabetes Epidemics in Korea: Reappraise Nationwide Survey of Diabetes "Diabetes in Korea 2007" | 김대중 |
| 2021 | | e-Health Interventions for Community-Dwelling Type 2 Diabetes: A Scoping Review | 신승수 |
| 2011 | | Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea | 김대중 |
| 2020 | | Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study | 김대중, 김혜진, 문소영, 이관우, 전자영, 한승진 |
| 2019 | | Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus | 김순선, 김진홍, 신성재, 양민재, 유병무, 이광재, 이기명, 정재연, 조효정, 황재철 |
| 2018 | | Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort | 김대중, 김혜진, 이관우, 전기홍, 전자영, 한승진 |
| 2011 | | Prevalence of Chronic Complications in Korean Patients with Type 2 Diabetes Mellitus Based on the Korean National Diabetes Program | 이관우 |
| 2019 | | Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study | 김대중, 김혜진, 문소영, 이관우, 전자영, 한승진 |
| 2019 | | The association of diabetes duration and glycemic control with depression in elderly men with type 2 diabetes mellitus | 김대중, 김혜진, 이관우, 한승진, 홍창형 |
